Skip to content

Operating margin at other companies

Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
-7.8%-18.9pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-4,974.3%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-3,927.5%-1,497pp
Septerna, Inc. logo
Septerna, Inc.SEPN
-77.1%-38.4pp
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-1,774.4%+1,437pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
7.4%-16.2pp

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$24.2M+10.7%
Net income-$19.9M+17.5%
EPS (diluted)-$0.42+38.2%

Balance sheet

See full
Cash & equivalents$78.1M+35.5%
Total debt$10.8M+37.8%
Total equity$471.5M+65.0%
Total assets$497.6M+64.7%

Cash flow

See full
Operating cash flow-$13.1M+35.5%
CapEx$86.0K-70.4%
Free cash flow-$13.1M+36.0%

Valuation

See full
Market cap$1.91B+309%

Returns & leverage

See full
Return on equity-28.3%
Debt / equity0.0×
Current ratio27.1×-3.9×